JPX · 4519.T
Chugai Pharmaceutical Co., Ltd.
¥6,822+¥169 (+2.54%)
Chugai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.24% below the high.
Loading market information…
JPX · 4549.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Eiken Chemical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.09% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Eiken Chemical Co., Ltd.’s forward annual dividend is ¥58 per share, paid semi-annual. The forward yield is 2.51% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Eiken Chemical Co., Ltd.’s next earnings report is currently expected on Jan 29, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Eiken Chemical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Eiken Chemical Co., Ltd. is a Japanese manufacturer and distributor specializing in clinical diagnostic products and medical equipment. The company excels in developing diagnostic solutions for diverse medical fields, encompassing biochemical analysis, immunology, serology, dry chemical assays, and automated diagnostic systems. A significant offering is the OC-SENSOR, an automated immunochemical fecal test designed to identify gastrointestinal bleeding linked to conditions such as colorectal cancer, polyps, and diverticulitis. Its comprehensive product portfolio further includes real-time turbidimeters, temperature-controlled equipment, various amplification and fluorescence detection reagents for research applications, and general detection kits. Eiken Chemical also produces a variety of microbiology-related products, alongside additional immunological and serological reagents. Established in Tokyo, Japan, in 1939, the company initially operated as Nihon Eiyokagaku Co., Ltd. until its rebranding to Eiken Chemical Co., Ltd. in 1969.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:48 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| ¥9.9B-1.4% vs estimate |
| Q3 2024 | Jan 31, 2025 | ¥23 | ¥10.91B0.0% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥6,822+¥169 (+2.54%)
Chugai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.24% below the high.
¥6,651+¥180 (+2.78%)
Takeda Pharmaceutical Company Limited’s quoted price sits in the upper half of its reported 52-week range, 0.91% below the high.
¥11,410+¥390 (+3.54%)
Fukuda Denshi Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 8.65% below the high.
¥1,617+¥32 (+1.99%)
Nihon Kohden Corporation’s quoted price sits in the upper half of its reported 52-week range, 14.27% below the high.
¥1,415+¥52 (+3.82%)
PHC Holdings Corporation’s quoted price sits in the upper half of its reported 52-week range, 16.47% below the high.
¥3,835+¥65 (+1.72%)
BML, Inc.’s quoted price sits in the lower half of its reported 52-week range, 12.54% below the high.
¥1,711+¥10 (+0.59%)
Mizuho Medy Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 11.35% below the high.
¥2,161+¥63 (+3.0%)
Techno Medica Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 22.46% below the high.
